| |
 |
|
Class Information
Number: 424/188.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.) > Amino acid sequence disclosed in whole or in part; or conjugate, complex, or fusion protein or fusion polypeptide including the same > Disclosed amino acid sequence derived from virus > Retroviridae (e.g., feline leukemia, etc.) > Immunodeficiency virus (e.g., hiv, etc.)
Description: Subject matter wherein the virus is one that is associated with an immunodeficiency syndrome such as AIDS in humans or an AIDS-related syndrome in animals.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 6399294 |
Nucleotide sequences of HIV-1 type (or subtype) O retrovirus antigens |
Jun. 4, 2002 |
| 6395541 |
Methods for the identification of compounds capable of inhibiting HIV-1 viral replication employing murine cell lines expressing human topoisomerase I |
May. 28, 2002 |
| 6391304 |
Peptides derived from the ENV gene of the feline immunodeficiency virus and their applications |
May. 21, 2002 |
| 6379679 |
Multiple branch peptide construction |
Apr. 30, 2002 |
| 6355247 |
Nucleic acid immunization using a virus-based infection/transfection system |
Mar. 12, 2002 |
| 6355789 |
CLONED DNA SEQUENCES RELATED TO THE ENTIRE GENOMIC RNA OF HUMAN IMMUNODEFICIENCY VIRUS II (HIV-2), POLYPEPTIDES ENCODED BY THESE DNA SEQUENCES AND USE OF THESE DNA CLONES AND POLYPEPTIDES IN D |
Mar. 12, 2002 |
| 6342228 |
Diagnostic kits comprising genetically engineered human immunodeficiency virus-like particles containing heterologous antigenic markers |
Jan. 29, 2002 |
| 6338952 |
Stress proteins and uses therefor |
Jan. 15, 2002 |
| 6337179 |
Methods and kits for detecting antibodies against an HIV variant |
Jan. 8, 2002 |
| 6335158 |
Methodologies for the detection of human immunodeficiency virus nucleic acids employing oligonucleotide primer derived from the HIV-1 MVP5180/91 genome |
Jan. 1, 2002 |
| 6335017 |
Compositions and methods for treating viral infections |
Jan. 1, 2002 |
| 6335183 |
Stress proteins and uses therefor |
Jan. 1, 2002 |
| 6331404 |
HIV envelope polypeptides |
Dec. 18, 2001 |
| 6331616 |
Nucleic acids obtained from the envelope coding region of feline immunodeficiency virus molecular clone designated JSY3 |
Dec. 18, 2001 |
| 6322964 |
Synthetic HIV-2 gag and env oligopeptides reactive with HIV-2 specific antibodies |
Nov. 27, 2001 |
| 6294174 |
Peptides immunologically related to known viral protein |
Sep. 25, 2001 |
| 6294322 |
Multideterminant peptides that elicit helper T-lymphocyte cytotoxic T-lymphocyte and neutralizing antibody responses against HIV-1 |
Sep. 25, 2001 |
| 6290963 |
Anti-HIV compositions containing native and recombinant peptides |
Sep. 18, 2001 |
| 6291227 |
Nucleic acids containing modified human immunodeficiency virus genomes devoid of long terminal repeats encoding non-infectious, replication-deficient, immunogenic retrovirus-like particles |
Sep. 18, 2001 |
| 6287568 |
Methods relating to immunogenic dextran-protein conjugates |
Sep. 11, 2001 |
| 6287565 |
Modified HGP-30 heteroconjugates, compositions and methods of use |
Sep. 11, 2001 |
| 6284454 |
Variant of LAV viruses |
Sep. 4, 2001 |
| 6284252 |
Transdominant TAT variants of the human immunodeficiency virus |
Sep. 4, 2001 |
| 6284248 |
Immunogenic compositions comprising soluble, non-cleavable, chimeric HIV-1 gp160-variants |
Sep. 4, 2001 |
| 6268472 |
Modified HGP-30 peptides, conjugates, compositions and methods of use |
Jul. 31, 2001 |
| 6265149 |
In vitro diagnostic methods and kits for the detection of HIV-2-specific antibodies |
Jul. 24, 2001 |
| 6261799 |
Expression cassettes encoding soluble, non-cleavable, chimeric HIV-1 GP160 variants, their methods of construction, and methods for the production of GP160 variants |
Jul. 17, 2001 |
| 6261558 |
Synthetic human neutralizing monoclonal antibodies to human immunodeficiency virus |
Jul. 17, 2001 |
| 6261564 |
Peptides of human immunodeficiency virus type 1 (HIV-1) |
Jul. 17, 2001 |
| 6261569 |
Retro-, inverso- and retro-inverso synthetic peptide analogues |
Jul. 17, 2001 |
| 6261571 |
Immunogenic compositions comprising dimeric forms of the human immunodeficiency virus type 2 (HIV-2) and simian immunodeficiency virus (SIV) envelope glycoproteins |
Jul. 17, 2001 |
| 6248328 |
HIV-1 virus isolates of a subtype and its differential diagnostics, a vaccine against HIV-1 virus infections of this subtype and method of producing same, use of the HIV-1 virus isolates |
Jun. 19, 2001 |
| 6235518 |
Recombinant immunogenic actinomycetale |
May. 22, 2001 |
| 6228369 |
Composition of trans-dominant variants of viral proteins for obtaining an anti-viral effect |
May. 8, 2001 |
| 6214347 |
Multideterminant peptides that elicit helper T-lymphocyte, cytotoxic T lymphocyte and neutralizing antibody responses against HIV-1 |
Apr. 10, 2001 |
| 6210903 |
Peptide derived from human immunodeficiency virus type 1 (HIV-1), isolate Ant70, containing an immunodominant epitope and it's use in immunodiagnostic assays |
Apr. 3, 2001 |
| 6207185 |
Method for inducing a systemic immune response to an HIV antigen |
Mar. 27, 2001 |
| 6193981 |
Methods and compositions for impairing multiplication of HIV-1 |
Feb. 27, 2001 |
| 6193982 |
Anti-cyanovirin antibody with an internal image of gp120, a method of use thereof, and a method of using a cyanovirin to induce an immune response to gp120 |
Feb. 27, 2001 |
| 6177253 |
Screening methods for the identification of anti-HIV compounds employing a cyclosporine-specific monoclonal antibody that cross-reacts with HIV-1 p24 |
Jan. 23, 2001 |
| 6174528 |
Synthetic peptides and vaccines comprising same |
Jan. 16, 2001 |
| 6171596 |
Oligomeric HIV-1 envelope glycoproteins |
Jan. 9, 2001 |
| 6165502 |
Protein-lipid vesicles and autogenous vaccine comprising the same |
Dec. 26, 2000 |
| 6165470 |
Albumin derivatives with therapeutic functions |
Dec. 26, 2000 |
| 6162439 |
Human immunodeficiency virus type 2 (HIV-2) polypeptides and methods of producing them |
Dec. 19, 2000 |
| 6153377 |
Synthetic DNA derived recombinant HIV antigens |
Nov. 28, 2000 |
| 6149910 |
Peptides for the detection of HIV-1 group O |
Nov. 21, 2000 |
| 6139843 |
Peptide compositions for the treatment of HIV |
Oct. 31, 2000 |
| 6140059 |
Methods for the obtention of human immunodeficiency virsus Type 1 envelope glycoproteins in native and oligomeric form employing recombinant chimeric antigens containing collagenase recognitio |
Oct. 31, 2000 |
| 6140114 |
Defective viral vaccine particles obtained in vivo or ex vivo |
Oct. 31, 2000 |
|
|
|
